About RSL Bioscience
RSL Bioscience is a Healthcare company based in Delhi (India) founded in 2013. It operates as a manufacturing of bio-pharmaceutical products in healthcare sectors. Its Indian entity Rsl Bioscience Private Limited reported revenue of ₹90.4 Lakh. RSL Bioscience offers products and services including Hepatology and Gastroenterology Products and Rheumatology and Orthopedics Products. Its focus areas include Biotechnology, Pharmaceutical Manufacturing, Bio-pharmaceutical Products and Medical Services.
Company details
RSL Bioscience Private Limited is identified as a research-based biotech company that develops and manufactures differentiated bio-pharmaceutical products across various sectors. It operates in areas such as hepatology, gastroenterology, rheumatology, orthopedics, critical care, and gynecology, with commercialization handled through marketing infrastructures. The company is driven by a team of motivated professionals, and efforts are made to achieve international benchmarks via quality assurance and customer relationship management. Products like ALFA-Q 10 and others are produced to meet health needs. (78 words)
- Headquarters Delhi, India
- SectorsHealthcare
- Email••••••••
- Social Facebook
- Legal Name Rsl Bioscience Private Limited
- Date of Incorporation 08 Oct, 2013
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹90.4 Lakh
FY 2023 · +30% YoY
- Net Profit₹21,704
FY 2023 · 0% margin
- EBITDA₹2.1 Lakh
FY 2023 · 2% margin
Associated legal entities of RSL Bioscience
RSL Bioscience operates through Rsl Bioscience Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rsl Bioscience Private Limited CIN U24100DL2013PTC258934 | Active | 08 Oct 2013 | New Delhi, Delhi | ₹0.9 Cr | 15 | 3 | View details |
Products & Services of RSL Bioscience
RSL Bioscience offers a comprehensive portfolio of products and services, including Hepatology and Gastroenterology Products and Rheumatology and Orthopedics Products.
Products for liver and digestive health are developed and manufactured by the company.
Products for joint and bone health are provided by the company.
Board of directors of Rsl Bioscience Private Limited (RSL Bioscience)
Rsl Bioscience Private Limited is the primary company behind RSL Bioscience. The board of Rsl Bioscience Private Limited currently have 3 directors; the longest-serving is Lokesh Nath Lal, appointed in 2013.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Lokesh Nath Lal DIN 06673276 | Director | 08 Oct 2013 | 13 yrs | Rsl Bioscience Private Limited |
| Ratnesh Kumar Karn DIN 06673307 | Director | 08 Oct 2013 | 13 yrs | Rsl Bioscience Private Limited |
| Santosh Kumar DIN 06673352 | Director | 08 Oct 2013 | 13 yrs | Rsl Bioscience Private Limited |
Financials of RSL Bioscience
Figures of Rsl Bioscience Private Limited, the primary company behind RSL Bioscience, for FY 2023. Revenue was ₹90.4 Lakh (+30% year on year). Net profit was ₹21,704 (0% margin). EBITDA was ₹2.1 Lakh (2% margin). Revenue has grown at a compounded annual rate of -23% over three years and -9% over five years.
- ₹90.4 LakhRevenue · FY 2023 · +30% YoY
- ₹21,704Net profit · 0% margin
- ₹2.1 LakhEBITDA · 2% margin
- ₹1 LakhPaid-up capital
- 15Employees (provident fund records)
- -23%Revenue CAGR, 3 years
- -9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Rsl Bioscience Private Limited are on its company page.
Detailed financial statements for RSL Bioscience
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of RSL Bioscience
Websites that share an audience with RSL Bioscience (rslbpl.com).
Websites whose visitors overlap most with RSL Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| facebook.com | 100% | 12.1B | #3 | View details |
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as RSL Bioscience (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RSL Bioscience
RSL Bioscience was founded in 2013.
RSL Bioscience is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind RSL Bioscience, Rsl Bioscience Private Limited, reported revenue of ₹90.4 Lakh for FY 2023, up 30% year on year.
RSL Bioscience Private Limited is identified as a research-based biotech company that develops and manufactures differentiated bio-pharmaceutical products across various sectors. It operates in areas such as hepatology, gastroenterology, rheumatology, orthopedics, critical care, and gynecology, with commercialization handled through marketing infrastructures. The company is driven by a team of motivated professionals, and efforts are made to achieve international benchmarks via quality assurance and customer relationship management. Products like ALFA-Q 10 and others are produced to meet health needs. (78 words).
RSL Bioscience offers Hepatology and Gastroenterology Products and Rheumatology and Orthopedics Products.
RSL Bioscience operates through Rsl Bioscience Private Limited.
The legal entities of RSL Bioscience currently have 3 directors, including Lokesh Nath Lal, Ratnesh Kumar Karn, Santosh Kumar.